Global Vial and Prefilled Syringe Market Research Report 2023

The global Vial and Prefilled Syringe market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Vial and Prefilled Syringe is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Vial and Prefilled Syringe is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Vial and Prefilled Syringe include BD (US), Gerresheimer (DE), Nipro Corporation (JP), Schott forma vitrum (DE), Ompi (IT), Baxter BioPharma Solution (US), ROVI CM (ES), Terumo (JP) and Vetter (DE), etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Vial and Prefilled Syringe, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vial and Prefilled Syringe.

The Vial and Prefilled Syringe market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Vial and Prefilled Syringe market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Vial and Prefilled Syringe manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Vial and Prefilled Syringe

1.2 Vial and Prefilled Syringe Segment by Type

1.2.1 Global Vial and Prefilled Syringe Market Value Comparison by Type (2023-2029)

1.2.2 Glass Vial and Prefilled Syringe

1.2.3 Polymer Vial and Prefilled Syringe

1.3 Vial and Prefilled Syringe Segment by Application

1.3.1 Global Vial and Prefilled Syringe Market Value by Application: (2023-2029)

1.3.2 Antithrombotics

1.3.3 Vaccines

1.3.4 Autoimmune Diseases

1.3.5 Anti-inflammatory Drugs

1.3.6 Others

1.4 Global Vial and Prefilled Syringe Market Size Estimates and Forecasts

1.4.1 Global Vial and Prefilled Syringe Revenue 2018-2029

1.4.2 Global Vial and Prefilled Syringe Sales 2018-2029

1.4.3 Global Vial and Prefilled Syringe Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Vial and Prefilled Syringe Sales Market Share by Manufacturers (2018-2023)

2.2 Global Vial and Prefilled Syringe Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Vial and Prefilled Syringe Average Price by Manufacturers (2018-2023)

2.4 Global Vial and Prefilled Syringe Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Vial and Prefilled Syringe, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Vial and Prefilled Syringe, Product Type & Application

2.7 Vial and Prefilled Syringe Market Competitive Situation and Trends

2.7.1 Vial and Prefilled Syringe Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Vial and Prefilled Syringe Players Market Share by Revenue

2.7.3 Global Vial and Prefilled Syringe Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Vial and Prefilled Syringe Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Vial and Prefilled Syringe Global Vial and Prefilled Syringe Sales by Region: 2018-2029

3.2.1 Global Vial and Prefilled Syringe Sales by Region: 2018-2023

3.2.2 Global Vial and Prefilled Syringe Sales by Region: 2024-2029

3.3 Global Vial and Prefilled Syringe Global Vial and Prefilled Syringe Revenue by Region: 2018-2029

3.3.1 Global Vial and Prefilled Syringe Revenue by Region: 2018-2023

3.3.2 Global Vial and Prefilled Syringe Revenue by Region: 2024-2029

3.4 North America Vial and Prefilled Syringe Market Facts & Figures by Country

3.4.1 North America Vial and Prefilled Syringe Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Vial and Prefilled Syringe Sales by Country (2018-2029)

3.4.3 North America Vial and Prefilled Syringe Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Vial and Prefilled Syringe Market Facts & Figures by Country

3.5.1 Europe Vial and Prefilled Syringe Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Vial and Prefilled Syringe Sales by Country (2018-2029)

3.5.3 Europe Vial and Prefilled Syringe Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Vial and Prefilled Syringe Market Facts & Figures by Country

3.6.1 Asia Pacific Vial and Prefilled Syringe Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Vial and Prefilled Syringe Sales by Country (2018-2029)

3.6.3 Asia Pacific Vial and Prefilled Syringe Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Vial and Prefilled Syringe Market Facts & Figures by Country

3.7.1 Latin America Vial and Prefilled Syringe Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Vial and Prefilled Syringe Sales by Country (2018-2029)

3.7.3 Latin America Vial and Prefilled Syringe Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Vial and Prefilled Syringe Market Facts & Figures by Country

3.8.1 Middle East and Africa Vial and Prefilled Syringe Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Vial and Prefilled Syringe Sales by Country (2018-2029)

3.8.3 Middle East and Africa Vial and Prefilled Syringe Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Vial and Prefilled Syringe Sales by Type (2018-2029)

4.1.1 Global Vial and Prefilled Syringe Sales by Type (2018-2023)

4.1.2 Global Vial and Prefilled Syringe Sales by Type (2024-2029)

4.1.3 Global Vial and Prefilled Syringe Sales Market Share by Type (2018-2029)

4.2 Global Vial and Prefilled Syringe Revenue by Type (2018-2029)

4.2.1 Global Vial and Prefilled Syringe Revenue by Type (2018-2023)

4.2.2 Global Vial and Prefilled Syringe Revenue by Type (2024-2029)

4.2.3 Global Vial and Prefilled Syringe Revenue Market Share by Type (2018-2029)

4.3 Global Vial and Prefilled Syringe Price by Type (2018-2029)

5.1 Global Vial and Prefilled Syringe Sales by Application (2018-2029)

5.1.1 Global Vial and Prefilled Syringe Sales by Application (2018-2023)

5.1.2 Global Vial and Prefilled Syringe Sales by Application (2024-2029)

5.1.3 Global Vial and Prefilled Syringe Sales Market Share by Application (2018-2029)

5.2 Global Vial and Prefilled Syringe Revenue by Application (2018-2029)

5.2.1 Global Vial and Prefilled Syringe Revenue by Application (2018-2023)

5.2.2 Global Vial and Prefilled Syringe Revenue by Application (2024-2029)

5.2.3 Global Vial and Prefilled Syringe Revenue Market Share by Application (2018-2029)

5.3 Global Vial and Prefilled Syringe Price by Application (2018-2029)

6.1 BD (US)

6.1.1 BD (US) Corporation Information

6.1.2 BD (US) Description and Business Overview

6.1.3 BD (US) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)

6.1.4 BD (US) Vial and Prefilled Syringe Product Portfolio

6.1.5 BD (US) Recent Developments/Updates

6.2 Gerresheimer (DE)

6.2.1 Gerresheimer (DE) Corporation Information

6.2.2 Gerresheimer (DE) Description and Business Overview

6.2.3 Gerresheimer (DE) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Gerresheimer (DE) Vial and Prefilled Syringe Product Portfolio

6.2.5 Gerresheimer (DE) Recent Developments/Updates

6.3 Nipro Corporation (JP)

6.3.1 Nipro Corporation (JP) Corporation Information

6.3.2 Nipro Corporation (JP) Description and Business Overview

6.3.3 Nipro Corporation (JP) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Nipro Corporation (JP) Vial and Prefilled Syringe Product Portfolio

6.3.5 Nipro Corporation (JP) Recent Developments/Updates

6.4 Schott forma vitrum (DE)

6.4.1 Schott forma vitrum (DE) Corporation Information

6.4.2 Schott forma vitrum (DE) Description and Business Overview

6.4.3 Schott forma vitrum (DE) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Schott forma vitrum (DE) Vial and Prefilled Syringe Product Portfolio

6.4.5 Schott forma vitrum (DE) Recent Developments/Updates

6.5 Ompi (IT)

6.5.1 Ompi (IT) Corporation Information

6.5.2 Ompi (IT) Description and Business Overview

6.5.3 Ompi (IT) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Ompi (IT) Vial and Prefilled Syringe Product Portfolio

6.5.5 Ompi (IT) Recent Developments/Updates

6.6 Baxter BioPharma Solution (US)

6.6.1 Baxter BioPharma Solution (US) Corporation Information

6.6.2 Baxter BioPharma Solution (US) Description and Business Overview

6.6.3 Baxter BioPharma Solution (US) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Baxter BioPharma Solution (US) Vial and Prefilled Syringe Product Portfolio

6.6.5 Baxter BioPharma Solution (US) Recent Developments/Updates

6.7 ROVI CM (ES)

6.6.1 ROVI CM (ES) Corporation Information

6.6.2 ROVI CM (ES) Description and Business Overview

6.6.3 ROVI CM (ES) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)

6.4.4 ROVI CM (ES) Vial and Prefilled Syringe Product Portfolio

6.7.5 ROVI CM (ES) Recent Developments/Updates

6.8 Terumo (JP)

6.8.1 Terumo (JP) Corporation Information

6.8.2 Terumo (JP) Description and Business Overview

6.8.3 Terumo (JP) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Terumo (JP) Vial and Prefilled Syringe Product Portfolio

6.8.5 Terumo (JP) Recent Developments/Updates

6.9 Vetter (DE)

6.9.1 Vetter (DE) Corporation Information

6.9.2 Vetter (DE) Description and Business Overview

6.9.3 Vetter (DE) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Vetter (DE) Vial and Prefilled Syringe Product Portfolio

6.9.5 Vetter (DE) Recent Developments/Updates

6.10 Unilife Corporation (US)

6.10.1 Unilife Corporation (US) Corporation Information

6.10.2 Unilife Corporation (US) Description and Business Overview

6.10.3 Unilife Corporation (US) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Unilife Corporation (US) Vial and Prefilled Syringe Product Portfolio

6.10.5 Unilife Corporation (US) Recent Developments/Updates

6.11 Taisei Kako (JP)

6.11.1 Taisei Kako (JP) Corporation Information

6.11.2 Taisei Kako (JP) Vial and Prefilled Syringe Description and Business Overview

6.11.3 Taisei Kako (JP) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)

6.11.4 Taisei Kako (JP) Vial and Prefilled Syringe Product Portfolio

6.11.5 Taisei Kako (JP) Recent Developments/Updates

6.12 Roselabs Group (IN)

6.12.1 Roselabs Group (IN) Corporation Information

6.12.2 Roselabs Group (IN) Vial and Prefilled Syringe Description and Business Overview

6.12.3 Roselabs Group (IN) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)

6.12.4 Roselabs Group (IN) Vial and Prefilled Syringe Product Portfolio

6.12.5 Roselabs Group (IN) Recent Developments/Updates

6.13 ARTE CORPORATION (JP)

6.13.1 ARTE CORPORATION (JP) Corporation Information

6.13.2 ARTE CORPORATION (JP) Vial and Prefilled Syringe Description and Business Overview

6.13.3 ARTE CORPORATION (JP) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)

6.13.4 ARTE CORPORATION (JP) Vial and Prefilled Syringe Product Portfolio

6.13.5 ARTE CORPORATION (JP) Recent Developments/Updates

6.14 Weigao Group Medical Polymer (CN)

6.14.1 Weigao Group Medical Polymer (CN) Corporation Information

6.14.2 Weigao Group Medical Polymer (CN) Vial and Prefilled Syringe Description and Business Overview

6.14.3 Weigao Group Medical Polymer (CN) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)

6.14.4 Weigao Group Medical Polymer (CN) Vial and Prefilled Syringe Product Portfolio

6.14.5 Weigao Group Medical Polymer (CN) Recent Developments/Updates

6.15 Zibo Minkang Pharmaceutical (CN)

6.15.1 Zibo Minkang Pharmaceutical (CN) Corporation Information

6.15.2 Zibo Minkang Pharmaceutical (CN) Vial and Prefilled Syringe Description and Business Overview

6.15.3 Zibo Minkang Pharmaceutical (CN) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)

6.15.4 Zibo Minkang Pharmaceutical (CN) Vial and Prefilled Syringe Product Portfolio

6.15.5 Zibo Minkang Pharmaceutical (CN) Recent Developments/Updates

6.16 Shandong Pharmaceutical Glass (CN)

6.16.1 Shandong Pharmaceutical Glass (CN) Corporation Information

6.16.2 Shandong Pharmaceutical Glass (CN) Vial and Prefilled Syringe Description and Business Overview

6.16.3 Shandong Pharmaceutical Glass (CN) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)

6.16.4 Shandong Pharmaceutical Glass (CN) Vial and Prefilled Syringe Product Portfolio

6.16.5 Shandong Pharmaceutical Glass (CN) Recent Developments/Updates

7.1 Vial and Prefilled Syringe Industry Chain Analysis

7.2 Vial and Prefilled Syringe Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Vial and Prefilled Syringe Production Mode & Process

7.4 Vial and Prefilled Syringe Sales and Marketing

7.4.1 Vial and Prefilled Syringe Sales Channels

7.4.2 Vial and Prefilled Syringe Distributors

7.5 Vial and Prefilled Syringe Customers

8.1 Vial and Prefilled Syringe Industry Trends

8.2 Vial and Prefilled Syringe Market Drivers

8.3 Vial and Prefilled Syringe Market Challenges

8.4 Vial and Prefilled Syringe Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Vial and Prefilled Syringe Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Vial and Prefilled Syringe Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Vial and Prefilled Syringe Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Vial and Prefilled Syringe Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Vial and Prefilled Syringe Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Vial and Prefilled Syringe Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Vial and Prefilled Syringe Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Vial and Prefilled Syringe Average Price (USD/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Vial and Prefilled Syringe, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Vial and Prefilled Syringe, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Vial and Prefilled Syringe, Product Type & Application

    Table 12. Global Key Manufacturers of Vial and Prefilled Syringe, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Vial and Prefilled Syringe by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vial and Prefilled Syringe as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Vial and Prefilled Syringe Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Vial and Prefilled Syringe Sales by Region (2018-2023) & (K Units)

    Table 18. Global Vial and Prefilled Syringe Sales Market Share by Region (2018-2023)

    Table 19. Global Vial and Prefilled Syringe Sales by Region (2024-2029) & (K Units)

    Table 20. Global Vial and Prefilled Syringe Sales Market Share by Region (2024-2029)

    Table 21. Global Vial and Prefilled Syringe Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Vial and Prefilled Syringe Revenue Market Share by Region (2018-2023)

    Table 23. Global Vial and Prefilled Syringe Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Vial and Prefilled Syringe Revenue Market Share by Region (2024-2029)

    Table 25. North America Vial and Prefilled Syringe Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Vial and Prefilled Syringe Sales by Country (2018-2023) & (K Units)

    Table 27. North America Vial and Prefilled Syringe Sales by Country (2024-2029) & (K Units)

    Table 28. North America Vial and Prefilled Syringe Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Vial and Prefilled Syringe Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Vial and Prefilled Syringe Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Vial and Prefilled Syringe Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Vial and Prefilled Syringe Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Vial and Prefilled Syringe Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Vial and Prefilled Syringe Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Vial and Prefilled Syringe Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Vial and Prefilled Syringe Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Vial and Prefilled Syringe Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Vial and Prefilled Syringe Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Vial and Prefilled Syringe Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Vial and Prefilled Syringe Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Vial and Prefilled Syringe Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Vial and Prefilled Syringe Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Vial and Prefilled Syringe Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Vial and Prefilled Syringe Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Vial and Prefilled Syringe Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Vial and Prefilled Syringe Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Vial and Prefilled Syringe Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Vial and Prefilled Syringe Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Vial and Prefilled Syringe Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Vial and Prefilled Syringe Sales (K Units) by Type (2018-2023)

    Table 51. Global Vial and Prefilled Syringe Sales (K Units) by Type (2024-2029)

    Table 52. Global Vial and Prefilled Syringe Sales Market Share by Type (2018-2023)

    Table 53. Global Vial and Prefilled Syringe Sales Market Share by Type (2024-2029)

    Table 54. Global Vial and Prefilled Syringe Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Vial and Prefilled Syringe Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Vial and Prefilled Syringe Revenue Market Share by Type (2018-2023)

    Table 57. Global Vial and Prefilled Syringe Revenue Market Share by Type (2024-2029)

    Table 58. Global Vial and Prefilled Syringe Price (USD/Unit) by Type (2018-2023)

    Table 59. Global Vial and Prefilled Syringe Price (USD/Unit) by Type (2024-2029)

    Table 60. Global Vial and Prefilled Syringe Sales (K Units) by Application (2018-2023)

    Table 61. Global Vial and Prefilled Syringe Sales (K Units) by Application (2024-2029)

    Table 62. Global Vial and Prefilled Syringe Sales Market Share by Application (2018-2023)

    Table 63. Global Vial and Prefilled Syringe Sales Market Share by Application (2024-2029)

    Table 64. Global Vial and Prefilled Syringe Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Vial and Prefilled Syringe Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Vial and Prefilled Syringe Revenue Market Share by Application (2018-2023)

    Table 67. Global Vial and Prefilled Syringe Revenue Market Share by Application (2024-2029)

    Table 68. Global Vial and Prefilled Syringe Price (USD/Unit) by Application (2018-2023)

    Table 69. Global Vial and Prefilled Syringe Price (USD/Unit) by Application (2024-2029)

    Table 70. BD (US) Corporation Information

    Table 71. BD (US) Description and Business Overview

    Table 72. BD (US) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 73. BD (US) Vial and Prefilled Syringe Product

    Table 74. BD (US) Recent Developments/Updates

    Table 75. Gerresheimer (DE) Corporation Information

    Table 76. Gerresheimer (DE) Description and Business Overview

    Table 77. Gerresheimer (DE) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 78. Gerresheimer (DE) Vial and Prefilled Syringe Product

    Table 79. Gerresheimer (DE) Recent Developments/Updates

    Table 80. Nipro Corporation (JP) Corporation Information

    Table 81. Nipro Corporation (JP) Description and Business Overview

    Table 82. Nipro Corporation (JP) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 83. Nipro Corporation (JP) Vial and Prefilled Syringe Product

    Table 84. Nipro Corporation (JP) Recent Developments/Updates

    Table 85. Schott forma vitrum (DE) Corporation Information

    Table 86. Schott forma vitrum (DE) Description and Business Overview

    Table 87. Schott forma vitrum (DE) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 88. Schott forma vitrum (DE) Vial and Prefilled Syringe Product

    Table 89. Schott forma vitrum (DE) Recent Developments/Updates

    Table 90. Ompi (IT) Corporation Information

    Table 91. Ompi (IT) Description and Business Overview

    Table 92. Ompi (IT) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 93. Ompi (IT) Vial and Prefilled Syringe Product

    Table 94. Ompi (IT) Recent Developments/Updates

    Table 95. Baxter BioPharma Solution (US) Corporation Information

    Table 96. Baxter BioPharma Solution (US) Description and Business Overview

    Table 97. Baxter BioPharma Solution (US) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 98. Baxter BioPharma Solution (US) Vial and Prefilled Syringe Product

    Table 99. Baxter BioPharma Solution (US) Recent Developments/Updates

    Table 100. ROVI CM (ES) Corporation Information

    Table 101. ROVI CM (ES) Description and Business Overview

    Table 102. ROVI CM (ES) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 103. ROVI CM (ES) Vial and Prefilled Syringe Product

    Table 104. ROVI CM (ES) Recent Developments/Updates

    Table 105. Terumo (JP) Corporation Information

    Table 106. Terumo (JP) Description and Business Overview

    Table 107. Terumo (JP) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 108. Terumo (JP) Vial and Prefilled Syringe Product

    Table 109. Terumo (JP) Recent Developments/Updates

    Table 110. Vetter (DE) Corporation Information

    Table 111. Vetter (DE) Description and Business Overview

    Table 112. Vetter (DE) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 113. Vetter (DE) Vial and Prefilled Syringe Product

    Table 114. Vetter (DE) Recent Developments/Updates

    Table 115. Unilife Corporation (US) Corporation Information

    Table 116. Unilife Corporation (US) Description and Business Overview

    Table 117. Unilife Corporation (US) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 118. Unilife Corporation (US) Vial and Prefilled Syringe Product

    Table 119. Unilife Corporation (US) Recent Developments/Updates

    Table 120. Taisei Kako (JP) Corporation Information

    Table 121. Taisei Kako (JP) Description and Business Overview

    Table 122. Taisei Kako (JP) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 123. Taisei Kako (JP) Vial and Prefilled Syringe Product

    Table 124. Taisei Kako (JP) Recent Developments/Updates

    Table 125. Roselabs Group (IN) Corporation Information

    Table 126. Roselabs Group (IN) Description and Business Overview

    Table 127. Roselabs Group (IN) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 128. Roselabs Group (IN) Vial and Prefilled Syringe Product

    Table 129. Roselabs Group (IN) Recent Developments/Updates

    Table 130. ARTE CORPORATION (JP) Corporation Information

    Table 131. ARTE CORPORATION (JP) Description and Business Overview

    Table 132. ARTE CORPORATION (JP) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 133. ARTE CORPORATION (JP) Vial and Prefilled Syringe Product

    Table 134. ARTE CORPORATION (JP) Recent Developments/Updates

    Table 135. Weigao Group Medical Polymer (CN) Corporation Information

    Table 136. Weigao Group Medical Polymer (CN) Description and Business Overview

    Table 137. Weigao Group Medical Polymer (CN) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 138. Weigao Group Medical Polymer (CN) Vial and Prefilled Syringe Product

    Table 139. Weigao Group Medical Polymer (CN) Recent Developments/Updates

    Table 140. Zibo Minkang Pharmaceutical (CN) Corporation Information

    Table 141. Zibo Minkang Pharmaceutical (CN) Description and Business Overview

    Table 142. Zibo Minkang Pharmaceutical (CN) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 143. Zibo Minkang Pharmaceutical (CN) Vial and Prefilled Syringe Product

    Table 144. Zibo Minkang Pharmaceutical (CN) Recent Developments/Updates

    Table 145. Shandong Pharmaceutical Glass (CN) Corporation Information

    Table 146. Shandong Pharmaceutical Glass (CN) Description and Business Overview

    Table 147. Shandong Pharmaceutical Glass (CN) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 148. Shandong Pharmaceutical Glass (CN) Vial and Prefilled Syringe Product

    Table 149. Shandong Pharmaceutical Glass (CN) Recent Developments/Updates

    Table 150. Key Raw Materials Lists

    Table 151. Raw Materials Key Suppliers Lists

    Table 152. Vial and Prefilled Syringe Distributors List

    Table 153. Vial and Prefilled Syringe Customers List

    Table 154. Vial and Prefilled Syringe Market Trends

    Table 155. Vial and Prefilled Syringe Market Drivers

    Table 156. Vial and Prefilled Syringe Market Challenges

    Table 157. Vial and Prefilled Syringe Market Restraints

    Table 158. Research Programs/Design for This Report

    Table 159. Key Data Information from Secondary Sources

    Table 160. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Vial and Prefilled Syringe

    Figure 2. Global Vial and Prefilled Syringe Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Vial and Prefilled Syringe Market Share by Type in 2022 & 2029

    Figure 4. Glass Vial and Prefilled Syringe Product Picture

    Figure 5. Polymer Vial and Prefilled Syringe Product Picture

    Figure 6. Global Vial and Prefilled Syringe Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Vial and Prefilled Syringe Market Share by Application in 2022 & 2029

    Figure 8. Antithrombotics

    Figure 9. Vaccines

    Figure 10. Autoimmune Diseases

    Figure 11. Anti-inflammatory Drugs

    Figure 12. Others

    Figure 13. Global Vial and Prefilled Syringe Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Vial and Prefilled Syringe Market Size (2018-2029) & (US$ Million)

    Figure 15. Global Vial and Prefilled Syringe Sales (2018-2029) & (K Units)

    Figure 16. Global Vial and Prefilled Syringe Average Price (USD/Unit) & (2018-2029)

    Figure 17. Vial and Prefilled Syringe Report Years Considered

    Figure 18. Vial and Prefilled Syringe Sales Share by Manufacturers in 2022

    Figure 19. Global Vial and Prefilled Syringe Revenue Share by Manufacturers in 2022

    Figure 20. The Global 5 and 10 Largest Vial and Prefilled Syringe Players: Market Share by Revenue in 2022

    Figure 21. Vial and Prefilled Syringe Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 22. Global Vial and Prefilled Syringe Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 23. North America Vial and Prefilled Syringe Sales Market Share by Country (2018-2029)

    Figure 24. North America Vial and Prefilled Syringe Revenue Market Share by Country (2018-2029)

    Figure 25. U.S. Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 26. Canada Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 27. Europe Vial and Prefilled Syringe Sales Market Share by Country (2018-2029)

    Figure 28. Europe Vial and Prefilled Syringe Revenue Market Share by Country (2018-2029)

    Figure 29. Germany Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. France Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. U.K. Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Italy Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Russia Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Asia Pacific Vial and Prefilled Syringe Sales Market Share by Region (2018-2029)

    Figure 35. Asia Pacific Vial and Prefilled Syringe Revenue Market Share by Region (2018-2029)

    Figure 36. China Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. Japan Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. South Korea Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. India Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Australia Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. China Taiwan Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Indonesia Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Thailand Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Malaysia Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Latin America Vial and Prefilled Syringe Sales Market Share by Country (2018-2029)

    Figure 46. Latin America Vial and Prefilled Syringe Revenue Market Share by Country (2018-2029)

    Figure 47. Mexico Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Brazil Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Argentina Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Middle East & Africa Vial and Prefilled Syringe Sales Market Share by Country (2018-2029)

    Figure 51. Middle East & Africa Vial and Prefilled Syringe Revenue Market Share by Country (2018-2029)

    Figure 52. Turkey Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Saudi Arabia Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. UAE Vial and Prefilled Syringe Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. Global Sales Market Share of Vial and Prefilled Syringe by Type (2018-2029)

    Figure 56. Global Revenue Market Share of Vial and Prefilled Syringe by Type (2018-2029)

    Figure 57. Global Vial and Prefilled Syringe Price (USD/Unit) by Type (2018-2029)

    Figure 58. Global Sales Market Share of Vial and Prefilled Syringe by Application (2018-2029)

    Figure 59. Global Revenue Market Share of Vial and Prefilled Syringe by Application (2018-2029)

    Figure 60. Global Vial and Prefilled Syringe Price (USD/Unit) by Application (2018-2029)

    Figure 61. Vial and Prefilled Syringe Value Chain

    Figure 62. Vial and Prefilled Syringe Production Process

    Figure 63. Channels of Distribution (Direct Vs Distribution)

    Figure 64. Distributors Profiles

    Figure 65. Bottom-up and Top-down Approaches for This Report

    Figure 66. Data Triangulation

    Figure 67. Key Executives Interviewed